Kolon Pharma

FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...

Kolon Industries Inc. has expanded the capacity of its polyester tire cord fabric plant in Vietnam, the South Korean company said on Wednesday.The f...

Kolon Global Corp., an affiliate of South Korean conglomerate Kolon, will spin off its car import business unit to improve management efficiency and...

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...

A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...

South Korean biotech and pharmaceutical companies are expanding their footholds in the global space medicine market. Boryung, formerly Boryung Pharm...

South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, plans to double the number of its biosimilar products on sale to 10 by 2025 and acce...

The field of ribonucleic acid (RNA) therapeutics, once considered an unexplored area, is now the most coveted sector in the global biotech industry....

South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...

Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...

South Korea’s textile sector is reviving as a high value-added growth business with advanced technology. The business, once a leading industry...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

Shares of hydrogen-related stocks such as Hyosung Advanced Materials Corp. and Kolon Industries Inc. are flying high on expectations of significant ...

Kolon will be the next major South Korean business group to join the race in the fast-growing space sector by developing and making light composite ...

As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...

Kolon Group’s industrial materials maker Kolon Industries Inc. saw a quarterly operating profit over 100 billion won ($87 million) for the fir...

South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...

South Korea’s chemicals and industrial materials maker Kolon Industries Inc. have added another 15,000 tons of annual capacity in its hydrocar...

Kolon Group is making a remarkable comeback this year to challenge its longtime rival Hyosung Group in future-growth segments including hydrogen. Ac...

German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...

South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...

South Korea’s chemical and textile company Kolon Industries Inc. will supply its patented colorless polyimide (CPI®) film for Xiaomi&rsquo...

SK Global Chemical Co., a petrochemical subsidiary of SK Innovation Co., will produce biodegradable plastics together with chemical and textile heav...

South Korea’s chemical and textile company Kolon Industries Inc. will supply its proprietary colorless polyimide (CPI®) film for the world...

Kolon Industries Inc., a South Korean chemical and textile manufacturing company, is readying for the mass production of a key material for fuel cells...

South Korea is emerging as a global production base for coronavirus vaccines and medicine thanks to its comprehensive production facilities alongside ...